»ó´Ü¿©¹é
±â»ç (Àüü 161°Ç)
[Journal Briefing] ´ÙÆı۸®Ç÷ÎÁø ¸®¾ó¿ùµå¿¡¼­µµ ½ÅÀåÇýÅà °Åµì È®ÀÎ Á¤¿¬ÁÖ ±âÀÚ 2024-03-15 15:42
[Drug Review] ÄÉ·»µð¾ÆÁ¤ Çã°¡¡¤±Þ¿©·Î
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴 Ä¡·á ¿ÏÀüü °¡µ¿
ÀÌ»óµ· ±âÀÚ 2024-03-13 14:56
[Interview] ¡°1Â÷ÀÇ·á ´Ü°è¼­ºÎÅÍ ´ç´¢º´¼º ½ÅÀåÁúȯ ½Ï ã¾Æ³» À߶ó³»ÀÚ¡± ÀÌ»óµ· ±âÀÚ 2024-03-13 14:15
[RTM] 2024³â ´ç´¢º´ °ü¸®Àü·« ¾÷µ¥ÀÌÆ® THE MOST 2024-02-07 14:50
[Journal Briefing] µÑ¶ó±Û·çŸÀÌµå ½ÅÀåÁúȯ À§Çè°¨¼Ò ÇýÅà ½Ã»ç Á¤¿¬ÁÖ ±âÀÚ 2024-02-07 14:25
¶óÀÎ
[Conference Report] SGLT-2i+TZD, Ç÷´çÁ¶Àý¿¡¼­ Ç¥ÀûÀå±â º¸È£È¿°ú±îÁö ½Ã³ÊÁö ±â´ë THE MOST 2024-02-07 13:19
[Journal Briefing] Áöº¸ÅÙź º´¿ë¿ä¹ýÀ¸·Î ½ÅÀå º¸È£È¿°ú ³ô¿© Á¤¿¬ÁÖ ±âÀÚ 2024-01-11 16:33
[Cover Story] 2Çü´ç´¢º´ ¾à¹°Ä¡·á ¾Ë°í¸®µë µû¶óÀâ±â ÀÌ»óµ· ±âÀÚ 2023-11-08 13:31
[Sub Story] Ç÷´ç¡¤µ¿¹ÝÁúȯ ¹¯°í ´äº¯¿¡ ºÎÇÕÇÏ´Â ¾àÁ¦Ã³¹æ ÀÌ»óµ· ±âÀÚ 2023-11-08 12:04
[Sub Story] ½ÉºÎÀü Àü¹æÀ§ Ä¿¹ö¿¡, ½ÅÀåÁúȯ±îÁö ÀÌ»óµ· ±âÀÚ 2023-11-07 18:59
¶óÀÎ
[Sub Story] ÇÕº´Áõ ¿¹¹æ, Ç÷´ç¡¤Ç÷¾Ð¡¤ÁöÁú Á¶ÀýÀÌ ¿ì¼± ÀÓ¼¼Çü ±âÀÚ 2023-11-07 17:40
[Conference Report] ¡°REMATCH ¿¬±¸ ´ç´¢º´ Ä¡·áÀü·«ÀÇ °ø¹é ä¿ï °Í¡± ÀÓ¼¼Çü ±âÀÚ 2023-11-07 16:21
[Sub Story] 1Â÷Ä¡·áÁ¦ ¼±ÅñâÁØ ¹«¾ùÀÌ ´Þ¶óÁ³³ª? ÀÌ»óµ· ±âÀÚ 2023-10-04 16:15
[Sub Story] ±¹³» °¡À̵å¶óÀΰú ¹æÇâ ¸ÂÃç°¡´Â ±Þ¿©±âÁØ ÀÓ¼¼Çü ±âÀÚ 2023-08-07 13:48
[Sub Story] CÇü°£¿° À¯ÀüÀÚ1¡¤2Çü ÃÊÄ¡·á DAA º¹ÇÕÁ¦ 8~12ÁÖ ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2023-08-07 10:27
¶óÀÎ
[Expert Opinion] ±¹³» ´ç´¢º´ Ä¡·á½ÃÀåÀÇ º¯È­¿Í DPP-4i/SGLT-2iÀÇ ÀÓ»óÀû¿ë THE MOST 2023-07-05 14:45
[Conference Report] ±¹³» ȯÀÚ ´ë»ó MET + DPP-4i + SGLT-2i º´¿ë¿ä¹ý ±Ù°Å Á¦½Ã ÀÓ¼¼Çü ±âÀÚ 2023-07-05 14:31
[Cover Story] ´ëÇÑ´ç´¢º´ÇÐȸ ¡®2023 ´ç´¢º´ Áø·áÁöħ¡¯ ÁýÁߺм® ÀÌ»óµ· ±âÀÚ 2023-06-05 15:27
[Deep in Guideline] ¡°½ÉºÎÀü µ¿¹Ý½Ã A1C ¹«°üÇÏ°Ô SGLT-2i ¿ì¼±¡± ÀÌ»óµ· ±âÀÚ 2023-06-05 15:20
[Interview] Æø³ÐÀº 2Çü´ç´¢º´ ȯÀÚ¿¡¼­ ÇýÅà ±â´ë ÀÓ¼¼Çü ±âÀÚ 2023-06-05 14:51
Back to Top